プラダーウィリー症候群治療薬の世界市場（～2026年）

• 英文タイトル：Global Prader-Willi Syndrome Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04348
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はプラダーウィリー症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別プラダーウィリー症候群治療薬の競争状況、市場シェア
・世界のプラダーウィリー症候群治療薬市場：種類別市場規模 2015年-2020年（ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他）
・世界のプラダーウィリー症候群治療薬市場：種類別市場規模予測 2021年-2026年（ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他）
・世界のプラダーウィリー症候群治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他）
・世界のプラダーウィリー症候群治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他）
・北米のプラダーウィリー症候群治療薬市場分析：米国、カナダ
・ヨーロッパのプラダーウィリー症候群治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのプラダーウィリー症候群治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のプラダーウィリー症候群治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのプラダーウィリー症候群治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Chong Kun Dang Pharmaceutical Corp.、Essentialis, Inc.、Ferring International Center S.A.、LG Life Sciences, Ltd.、P2D Bioscience、Pfizer Inc.、Rhythm Pharmaceuticals
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Prader-Willi Syndrome Therapeutics Market
The global Prader-Willi Syndrome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Prader-Willi Syndrome Therapeutics Scope and Market Size
Prader-Willi Syndrome Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prader-Willi Syndrome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Chong Kun Dang Pharmaceutical Corp.
Essentialis, Inc.
Ferring International Center S.A.
LG Life Sciences, Ltd.
P2D Bioscience
Pfizer Inc.
Rhythm Pharmaceuticals
…

Market segment by Type, the product can be split into
Beloranib
Betahistine Hydrochloride
Diazoxide Choline CR
FE-992097
NOX-B11
Others
Market segment by Application, split into
Clinic
Hospital
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prader-Willi Syndrome Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Prader-Willi Syndrome Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Beloranib
1.4.3 Betahistine Hydrochloride
1.4.4 Diazoxide Choline CR
1.4.5 FE-992097
1.4.6 NOX-B11
1.4.7 Others
1.5 Market by Application
1.5.1 Global Prader-Willi Syndrome Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Prader-Willi Syndrome Therapeutics Market Perspective (2015-2026)
2.2 Global Prader-Willi Syndrome Therapeutics Growth Trends by Regions
2.2.1 Prader-Willi Syndrome Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prader-Willi Syndrome Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Prader-Willi Syndrome Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prader-Willi Syndrome Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Prader-Willi Syndrome Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Prader-Willi Syndrome Therapeutics Players by Market Size
3.1.1 Global Top Prader-Willi Syndrome Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Prader-Willi Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prader-Willi Syndrome Therapeutics Market Concentration Ratio
3.2.1 Global Prader-Willi Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prader-Willi Syndrome Therapeutics Revenue in 2019
3.3 Prader-Willi Syndrome Therapeutics Key Players Head office and Area Served
3.4 Key Players Prader-Willi Syndrome Therapeutics Product Solution and Service
3.5 Date of Enter into Prader-Willi Syndrome Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Prader-Willi Syndrome Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)
5.2 Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
6.2 Prader-Willi Syndrome Therapeutics Key Players in North America (2019-2020)
6.3 North America Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
6.4 North America Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
7.2 Prader-Willi Syndrome Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
7.4 Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
8.2 Prader-Willi Syndrome Therapeutics Key Players in China (2019-2020)
8.3 China Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
8.4 China Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
9.2 Prader-Willi Syndrome Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
9.4 Japan Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
10.2 Prader-Willi Syndrome Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
11.2 Prader-Willi Syndrome Therapeutics Key Players in India (2019-2020)
11.3 India Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
11.4 India Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Prader-Willi Syndrome Therapeutics Market Size (2015-2020)
12.2 Prader-Willi Syndrome Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Chong Kun Dang Pharmaceutical Corp.
13.1.1 Chong Kun Dang Pharmaceutical Corp. Company Details
13.1.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
13.1.3 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Introduction
13.1.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020))
13.1.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
13.2 Essentialis, Inc.
13.2.1 Essentialis, Inc. Company Details
13.2.2 Essentialis, Inc. Business Overview
13.2.3 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Introduction
13.2.4 Essentialis, Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020)
13.2.5 Essentialis, Inc. Recent Development
13.3 Ferring International Center S.A.
13.3.1 Ferring International Center S.A. Company Details
13.3.2 Ferring International Center S.A. Business Overview
13.3.3 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Introduction
13.3.4 Ferring International Center S.A. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020)
13.3.5 Ferring International Center S.A. Recent Development
13.4 LG Life Sciences, Ltd.
13.4.1 LG Life Sciences, Ltd. Company Details
13.4.2 LG Life Sciences, Ltd. Business Overview
13.4.3 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Introduction
13.4.4 LG Life Sciences, Ltd. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020)
13.4.5 LG Life Sciences, Ltd. Recent Development
13.5 P2D Bioscience
13.5.1 P2D Bioscience Company Details
13.5.2 P2D Bioscience Business Overview
13.5.3 P2D Bioscience Prader-Willi Syndrome Therapeutics Introduction
13.5.4 P2D Bioscience Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020)
13.5.5 P2D Bioscience Recent Development
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Details
13.6.2 Pfizer Inc. Business Overview
13.6.3 Pfizer Inc. Prader-Willi Syndrome Therapeutics Introduction
13.6.4 Pfizer Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020)
13.6.5 Pfizer Inc. Recent Development
13.7 Rhythm Pharmaceuticals
13.7.1 Rhythm Pharmaceuticals Company Details
13.7.2 Rhythm Pharmaceuticals Business Overview
13.7.3 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Introduction
13.7.4 Rhythm Pharmaceuticals Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020)
13.7.5 Rhythm Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Prader-Willi Syndrome Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Prader-Willi Syndrome Therapeutics Revenue
Table 3. Ranking of Global Top Prader-Willi Syndrome Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prader-Willi Syndrome Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Beloranib
Table 6. Key Players of Betahistine Hydrochloride
Table 7. Key Players of Diazoxide Choline CR
Table 8. Key Players of FE-992097
Table 9. Key Players of NOX-B11
Table 10. Key Players of Others
Table 11. Global Prader-Willi Syndrome Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Prader-Willi Syndrome Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Prader-Willi Syndrome Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Prader-Willi Syndrome Therapeutics Market Share by Regions (2015-2020)
Table 15. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Prader-Willi Syndrome Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Prader-Willi Syndrome Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Prader-Willi Syndrome Therapeutics Players
Table 22. Global Prader-Willi Syndrome Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Prader-Willi Syndrome Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Prader-Willi Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prader-Willi Syndrome Therapeutics as of 2019)
Table 25. Global Prader-Willi Syndrome Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Prader-Willi Syndrome Therapeutics Product Solution and Service
Table 28. Date of Enter into Prader-Willi Syndrome Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Prader-Willi Syndrome Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Prader-Willi Syndrome Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Prader-Willi Syndrome Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 38. North America Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 40. North America Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 44. Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 46. Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 50. China Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 52. China Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 56. Japan Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 58. Japan Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 68. India Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 70. India Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Prader-Willi Syndrome Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Prader-Willi Syndrome Therapeutics Market Share (2019-2020)
Table 74. Central & South America Prader-Willi Syndrome Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Prader-Willi Syndrome Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Prader-Willi Syndrome Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Prader-Willi Syndrome Therapeutics Market Share by Application (2015-2020)
Table 78. Chong Kun Dang Pharmaceutical Corp. Company Details
Table 79. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 80. Chong Kun Dang Pharmaceutical Corp. Product
Table 81. Chong Kun Dang Pharmaceutical Corp. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 82. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 83. Essentialis, Inc. Company Details
Table 84. Essentialis, Inc. Business Overview
Table 85. Essentialis, Inc. Product
Table 86. Essentialis, Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 87. Essentialis, Inc. Recent Development
Table 88. Ferring International Center S.A. Company Details
Table 89. Ferring International Center S.A. Business Overview
Table 90. Ferring International Center S.A. Product
Table 91. Ferring International Center S.A. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 92. Ferring International Center S.A. Recent Development
Table 93. LG Life Sciences, Ltd. Company Details
Table 94. LG Life Sciences, Ltd. Business Overview
Table 95. LG Life Sciences, Ltd. Product
Table 96. LG Life Sciences, Ltd. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 97. LG Life Sciences, Ltd. Recent Development
Table 98. P2D Bioscience Company Details
Table 99. P2D Bioscience Business Overview
Table 100. P2D Bioscience Product
Table 101. P2D Bioscience Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 102. P2D Bioscience Recent Development
Table 103. Pfizer Inc. Company Details
Table 104. Pfizer Inc. Business Overview
Table 105. Pfizer Inc. Product
Table 106. Pfizer Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 107. Pfizer Inc. Recent Development
Table 108. Rhythm Pharmaceuticals Company Details
Table 109. Rhythm Pharmaceuticals Business Overview
Table 110. Rhythm Pharmaceuticals Product
Table 111. Rhythm Pharmaceuticals Revenue in Prader-Willi Syndrome Therapeutics Business (2015-2020) (Million US$)
Table 112. Rhythm Pharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prader-Willi Syndrome Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Beloranib Features
Figure 3. Betahistine Hydrochloride Features
Figure 4. Diazoxide Choline CR Features
Figure 5. FE-992097 Features
Figure 6. NOX-B11 Features
Figure 7. Others Features
Figure 8. Global Prader-Willi Syndrome Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Prader-Willi Syndrome Therapeutics Report Years Considered
Figure 13. Global Prader-Willi Syndrome Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Prader-Willi Syndrome Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Prader-Willi Syndrome Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Prader-Willi Syndrome Therapeutics Market Share by Players in 2019
Figure 18. Global Top Prader-Willi Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prader-Willi Syndrome Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Prader-Willi Syndrome Therapeutics Revenue in 2019
Figure 20. North America Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

シェーグレン症候群治療薬の世界市場（～2026年）

Global Sjogren's Syndrome Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04626 2020年11月20日 99Pages
当調査資料はシェーグレン症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（一次、二次）市場規模、用途別（臨床、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メ...

骨髄異形成症候群（MDS）治療薬の世界市場（～2026年）

Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY03884 2020年11月20日 95Pages
当調査資料は骨髄異形成症候群（MDS）治療薬のグローバル市場について調査・分析したレポートです。種類別（アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）市場規模、用途別（入院患者、外来患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

レット症候群治療薬の世界市場（～2026年）

Global Rett Syndrome Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04506 2020年11月20日 95Pages
当調査資料はレット症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

ドラベ症候群治療薬の世界市場（～2026年）

Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11710 2020年11月25日 98Pages
当調査資料はドラベ症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

ドラベ症候群治療の世界市場（～2026年）

Global Dravet Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11711 2020年11月25日 97Pages
当調査資料はドラベ症候群治療のグローバル市場について調査・分析したレポートです。種類別（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

脆弱X症候群の世界市場（～2026年）

Global Fragile X Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY11990 2020年11月25日 95Pages
当調査資料は脆弱X症候群のグローバル市場について調査・分析したレポートです。種類別（ACT-01、AMO-01、ANAVEX-273、AUT-00206、ブリオスタチン-1、カンナビジオール、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

クッシング症候群治療の世界市場（～2026年）

Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11542 2020年11月25日 96Pages
当調査資料はクッシング症候群治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

クッシング症候群・先端巨大症治療の世界市場（～2026年）

Global Cushing's Syndrome and Acromegaly Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11541 2020年11月25日 92Pages
当調査資料はクッシング症候群・先端巨大症治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

ギランバレー症候群の世界市場（～2026年）

Global Guillain-Barré Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY12078 2020年11月25日 97Pages
当調査資料はギランバレー症候群のグローバル市場について調査・分析したレポートです。種類別（静脈内免疫グロブリン、血漿交換、鎮痛薬、抗痙攣薬、LMWH）市場規模、用途別（病院薬局、小売薬局、在宅医療、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

急性冠症候群治療薬の世界市場（～2026年）

Global Acute Coronary Syndrome Therapeutics Market Insights and Forecast to 2026
MRC2-11QY02086 2020年11月20日 111Pages
当調査資料は急性冠症候群治療薬のグローバル市場について調査・分析したレポートです。種類別（急性冠症候群第I相薬、急性冠症候群第II相薬、急性冠症候群第III相薬）市場規模、用途別（病院、クリニック、在宅ケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

シェーグレン症候群治療薬の世界市場（～2026年） Sjogren’s syndrome is an inflammatory disorder characterized by lymphocytic infiltrates in exocrine organs, primarily in lacrimal and salivary glands, resulting in classic sicca symptoms of dry mouth (xerostomia) and dry eyes (xerophthalmia). The disorder segmented into primary and secondary. The di…
骨髄異形成症候群（MDS）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Myelodysplastic Syndrome (MDS) Therapeutics Market The global Myelodysplastic Syndrome (MDS) Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Myelodysplastic Syndrome (M…
レット症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rett Syndrome Therapeutics Market The global Rett Syndrome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rett Syndrome Therapeutics Scope and Market Size Rett Syndrom…
ドラベ症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Dravet Syndrome Thereapeutics Scope and Market Size Dra…
脆弱X症候群の世界市場（～2026年） Market Analysis and Insights: Global Fragile X Syndrome Market The global Fragile X Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fragile X Syndrome Scope and Market Size Fragile X Syndrome market is segment…